Indications
| Indication Category | Clinical Context |
|---|---|
| Native kidney — glomerular disease | Unexplained progressive renal failure or AKI; nephrotic syndrome; significant non-nephrotic proteinuria (>1 g/day); glomerular hematuria; systemic diseases with renal involvement (lupus, vasculitis, amyloid) |
| Transplant kidney | Acute or chronic rejection evaluation; protocol biopsy (subclinical rejection precedes clinical signs); recurrent or de novo glomerular disease; unexplained graft dysfunction |
| Focal renal mass | Indeterminate solid renal mass before surgical or ablative treatment; Bosniak category III cystic lesions; required before percutaneous ablation per AUA guidelines for masses <3 cm |
Contraindications
| Type | Contraindication |
|---|---|
| Absolute | Active pyelonephritis or overlying skin/soft tissue infection along planned biopsy trajectory |
| Relative | Coagulopathy (INR >1.5–1.8, platelets <50,000); uncontrolled hypertension (SBP >140–160 mmHg); hydronephrosis; atrophic kidneys (<9 cm — fewer glomeruli, higher risk); multiple cysts obscuring safe access |
Blood pressure is critical: Target SBP <140 mmHg before proceeding. The risk increase is dramatic and continuous — 10× at SBP >140, 23× at SBP >170, and odds ratio 75.6 at SBP >180/DBP >95. This is a procedure that should be postponed until BP is adequately controlled. Note that some antihypertensives (calcium channel blockers, clonidine, hydralazine) may impair hemostasis after vessel trauma — factor this into periprocedural management.
Relevant Anatomy
Native Kidney
The native kidney is approached from the posterolateral flank, with the patient prone. The lower pole is the preferred target for native kidney biopsy — it is farthest from the renal hilum (artery, vein, ureter) and the collecting system, and is richest in cortical glomeruli. In normal renal ultrasound, the medullary pyramids are hypoechoic (darker) or anechoic (black) compared to the surrounding cortex, which is slightly more echogenic — use this distinction to guide needle depth. The outer half to outer third of the cortex is the target zone; any deeper trajectory toward the medulla dramatically increases risk of major vascular injury.
Transplant Kidney
The transplant kidney is superficial and lies in the iliac fossa, approached from the anterolateral aspect with the patient supine. The lower pole is preferred — the upper pole is close to the iliac vessels and should be avoided. Despite easy access, the proximity to the external iliac artery and vein requires careful Doppler assessment before every pass. The same cortical tangential approach applies.
Pre-Procedure Checklist
Imaging Review
- Prior cross-sectional imaging to confirm kidney anatomy and target location
- For focal mass: confirm lesion is visible on US; plan approach; consider CT guidance for morbidly obese patients or occult lesions
- Color Doppler to identify vessels in planned trajectory before any needle placement
Labs and Patient Assessment
- CBC with platelets; PT/INR and PTT; type and screen; serum creatinine/eGFR
- Target INR <1.5; platelets >50,000 (higher thresholds for elevated-risk patients)
- Blood pressure measurement — postpone if SBP >140–160 mmHg without adequate antihypertensive management
- Hold anticoagulation per SIR Category 3 guidelines
Consent Considerations
Discuss with the patient: perirenal hematoma (most common complication; ~90% minor, ~1–2% clinically significant), gross hematuria (~3–5%, usually self-limited), AV fistula (~15% on Doppler; 95% asymptomatic and self-resolving), arterial pseudoaneurysm (rare), urinary obstruction, infection, need for transfusion or embolization, graft loss (transplant), and death (extremely rare).
Procedure Overview
The following is a high-level summary. Full step-by-step technique, equipment selection, and specimen handling are available in RadCall Pro.
- Positioning — prone (native kidney); supine (transplant); confirm kidney position and lower pole with pre-procedure US survey; measure skin-to-capsule distance
- Doppler survey and trajectory planning — color Doppler to confirm no large vessel in the planned needle path; plan cortical tangential trajectory parallel to outer capsule in the lower pole posterior cortex
- Sterile prep and local anesthesia — sterile prep and drape; infiltrate local anesthesia from skin to kidney capsule under US guidance; do not puncture the capsule with the anesthesia needle
- Cortical tangential needle placement — advance needle toward the lower pole posterior cortex along a trajectory parallel to the outer capsule; the needle fires through the outer cortex, not across the full kidney diameter
- Breath-hold and firing — ask patient to hold breath in expiration before firing; obtain core specimen; withdraw immediately after firing
- Post-pass US check — scan for hematoma after each pass before proceeding; do not fire the next pass without surveying
- Repeat as needed — 1–2 passes with cortical tangential technique is typically sufficient for native kidney biopsy; examine cores under dissecting microscope if available to confirm glomeruli
- Specimen distribution — three containers required for native kidney: formalin (light microscopy), glutaraldehyde (electron microscopy), and saline or Michel's media (immunofluorescence); confirm requirements with pathology before starting
Complications
| Complication | Rate | Recognition & Management |
|---|---|---|
| Perirenal hematoma | ~90% minor; ~1–2% clinically significant | Post-procedure observation with serial vital signs; CT for pain, hemodynamic change, or significant Hgb drop; angiography and embolization for active arterial bleeding |
| Gross hematuria | ~3–5% | Usually self-limited (clears within 48–72h); hydration; Foley catheter for urinary retention from clot; cystoscopy or embolization for persistent significant bleeding |
| AV fistula | ~15% on Doppler; 95% asymptomatic | 46.6% resolve by 30 days; 95.4% by 3 months; intervene only for persistent hematuria, resistant hypertension, high-output heart failure, or AKI; angiography and embolization |
| Arterial pseudoaneurysm | Rare | Angiography and selective embolization |
| Page kidney | Rare | Subcapsular hematoma compresses parenchyma causing renovascular hypertension (RAAS activation); diagnosed by renin measurement; managed by surgical or percutaneous drainage |
| Death | Extremely rare (<0.1%) | Massive uncontrolled hemorrhage; higher risk with coagulopathy and uncontrolled hypertension |
Post-Procedure Care
Monitoring
- 4–6 hours observation; some centers admit overnight for high-risk cases (coagulopathy, solitary kidney, significant hypertension)
- Vitals every 30 minutes for 2 hours, then every 1 hour
- Urine color monitoring — document and serially assess gross hematuria
- Blood pressure control post-procedure — hypertension significantly increases post-biopsy bleeding risk
Discharge and Instructions
- Discharge criteria: stable vitals, no gross hematuria (or clearly improving), tolerating oral intake, hemoglobin stable
- Bed rest for 24 hours; avoid strenuous activity for 1–2 weeks
- Drink extra fluids
- Return immediately for: flank pain, bright red urine, hypotension, or dizziness
When to Escalate
- Active arterial hemorrhage or expanding hematoma — urgent angiography and selective embolization; surgical backup if embolization fails
- Significant gross hematuria with clot retention — Foley catheter irrigation; urology consultation for cystoscopy; embolization for active renal arterial source
- Post-biopsy hypertension — do not assume this is baseline hypertension; evaluate for Page kidney (subcapsular hematoma with RAAS activation); CT or US to assess for hematoma
- Hemodynamically significant AV fistula (persistent hematuria, high-output heart failure, or AKI) — angiography and selective embolization
References
- SIR Quality Improvement Guidelines for Percutaneous Needle Biopsy.
- Silverman SG, et al. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology. 2006;240(1):6–22.
- Kumari D. Semin Interv Radiol. 2024;41:486–493.